Value Proposition:
· Detection of methylation patterns that are linked to prostate cancer development in an individual.
· Enable development of a personalized treatment plan for individuals with aggressive prostate cancer.
· Simultaneous determination of gene methylation and copy number.
Technology Description
Researchers...
Unmet Need
Prostate cancer is one of the most commonly diagnosed cancers in the male population; roughly one out of ten men will be diagnosed at some point in their lives. Efficient screening and accurate diagnosis is a public health imperative due to the large potential patient population. Prostate cancer is usually diagnosed following an abnormal...
Novelty:
Five HOXB13 markers (G84E, L144P, Y88D, G216C, R229G) for identifying men with high risk of developing early-onset and hereditary prostate cancer.
Value Proposition:
Currently, there are no reliable genetic markers to assess risk for prostate cancer and the PSA test is known to lead to over-diagnosis of men with prostate cancer. To address...
